title: One hundred nine living donor liver transplants in adults and children: a single-center experience.
abstract: OBJECTIVE
  To summarize the evolution of a living donor liver transplant program and the authors' experience with 109 cases.
  
  
  BACKGROUND
  The authors' institution began to offer living donor liver transplants to children in 1993 and to adults in 1998.
  
  
  METHODS
  Donors were healthy, ages 18 to 60 years, related or unrelated, and ABO-compatible (except in one case). Donor evaluation was thorough. Liver biopsy was performed for abnormal lipid profiles or a history of significant alcohol use, a body mass index more than 28, or suspected steatosis. Imaging studies included angiography, computed tomography, endoscopic retrograde cholangiopancreatography, and magnetic resonance imaging. Recipient evaluation and management were the same as for cadaveric transplant.
  
  
  RESULTS
  After ABO screening, 136 potential donors were evaluated for 113 recipients; 23 donors withdrew for medical or personal reasons. Four donor surgeries were aborted; 109 transplants were performed. Fifty children (18 years or younger) received 47 left lateral segments and 3 left lobes; 59 adults received 50 right lobes and 9 left lobes. The average donor hospital stay was 6 days. Two donors each required one unit of banked blood. Right lobe donors had three bile leaks from the cut surface of the liver; all resolved. Another right lobe donor had prolonged hyperbilirubinemia. Three donors had small bowel obstructions; two required operation. All donors are alive and well. The most common indications for transplant were biliary atresia in children (56%) and hepatitis C in adults (40%); 35.6% of adults had hepatocellular carcinoma. Biliary reconstructions in all children and 44 adults were with a Roux-en-Y hepaticojejunostomy; 15 adults had duct-to-duct anastomoses. The incidence of major vascular complications was 12% in children and 11.8% in adult recipients. Children had three bile leaks (6%) and six (12%) biliary strictures. Adult patients had 14 (23.7%) bile leaks and 4 (6.8%) biliary strictures. Patient and graft survival rates were 87.6% and 81%, respectively, at 1 year and 75.1% and 69.6% at 5 years. In children, patient and graft survival rates were 89.9% and 85.8%, respectively, at 1 year and 80.9% and 78% at 5 years. In adults, patient and graft survival rates were 85.6% and 77%, respectively, at 1 year.
  
  
  CONCLUSIONS
  Living donor liver transplantation has become an important option for our patients and has dramatically changed our approach to patients with liver failure. The donor surgery is safe and can be done with minimal complications. We expect that living donor liver transplants will represent more than 50% of our transplants within 3 years.
authors.affiliation: Recanati/Miller Transplantation Institute, Mount Sinai Hospital, Mount Sinai School of Medicine, New York, New York 10029, USA. charles.miller@mountsinai.org
authors.forename: C M
authors.initials: CM
authors.lastname: Miller
authors.forename: G E
authors.initials: GE
authors.lastname: Gondolesi
authors.forename: S
authors.initials: S
authors.lastname: Florman
authors.forename: C
authors.initials: C
authors.lastname: Matsumoto
authors.forename: L
authors.initials: L
authors.lastname: Muñoz
authors.forename: T
authors.initials: T
authors.lastname: Yoshizumi
authors.forename: T
authors.initials: T
authors.lastname: Artis
authors.forename: T M
authors.initials: TM
authors.lastname: Fishbein
authors.forename: P A
authors.initials: PA
authors.lastname: Sheiner
authors.forename: L
authors.initials: L
authors.lastname: Kim-Schluger
authors.forename: T
authors.initials: T
authors.lastname: Schiano
authors.forename: B L
authors.initials: BL
authors.lastname: Shneider
authors.forename: S
authors.initials: S
authors.lastname: Emre
authors.forename: M E
authors.initials: ME
authors.lastname: Schwartz
mesh_terms: D000017:ABO Blood-Group System; D000293:Adolescent; D000328:Adult; D001656:Biliary Atresia / Q000601:surgery; D006528:Carcinoma, Hepatocellular / Q000150:complications; D002648:Child; D006085:Graft Survival; D006498:Hepatectomy / Q000379:methods; D006526:Hepatitis C / Q000601:surgery; D006801:Humans; D007902:Length of Stay; D008113:Liver Neoplasms / Q000150:complications; D016031:Liver Transplantation / Q000379:methods; D008875:Middle Aged; D011183:Postoperative Complications; D014019:Tissue Donors
chemical_list: D000017:ABO Blood-Group System